Role of factor VIII-binding capacity of endogenous von Willebrand factor in the development of factor VIII inhibitors in patients with severe hemophilia A

被引：3

作者：

Repesse, Yohann ^{[1
,2
,3
]}

Costa, Catherine ^{[4
]}

Palla, Roberta ^{[5
]}

Moshai, Elika Farrokhi ^{[6
]}

Borel-Derlon, Annie ^{[1
,2
,3
]}

D'Oiron, Roseline ^{[7
]}

Rothschild, Chantal ^{[8
]}

El-Beshlawy, Amal ^{[9
]}

Elalfy, Mohsen ^{[10
]}

Ramanan, Vijay ^{[11
]}

Eshghi, Peyman ^{[12
]}

Oldenburg, Johannes ^{[13
]}

Pavlova, Anna ^{[13
]}

Rosendaal, Frits R. ^{[14
]}

Peyvandi, Flora ^{[5
]}

Kaveri, Srinivas V. ^{[6
]}

Lacroix-Desmazes, Sebastien ^{[6
]}

机构：

[1] CHU Caen, Hematol Lab, Caen, France

[2] INSERM, U1237, GIP Cyceron, Caen, France

[3] Normandie Univ, UNI CAEN, UFR Sante, Caen, France

[4] Grp Hosp Cochin Broca, AP HP, Hotel Dieu, Serv Genet & Biol Mol, Site Cochin, Paris, France

[5] Univ Milan, Dept Pathophysiol & Transplantat, Milan, Italy

[6] Univ Paris Diderot, Sorbonne Univ, USPC, Ctr Rech Cordeliers,INSERM, Paris, France

[7] AP HP, Ctr Traitement Hemophilie, Le Kremlin Bicetre, France

[8] Hop Necker Enfants Malad, AP HP, Ctr Traitement Hemophilie, Paris, France

[9] Cairo Univ, Pediat Hosp, Pediat Hematol Dept, Cairo, Egypt

[10] Cairo Univ, Ain Shams Ctr, Dept Pediat, Fac Med, Cairo, Egypt

[11] Jehangir Hosp Premises, Jehangir Clin Dev Ctr, Dept Hematol, Pune, Maharashtra, India

[12] Shahid Beheshti Univ Med Sci, Pediat Congenital Hematol Disorders Res Ctr, Tehran, Iran

[13] Univ Clin Bonn, Inst Expt Hematol & Transfus Med, Bonn, Germany

[14] Leiden Univ, Med Ctr, Dept Clin Epidemiol, Leiden, Netherlands

来源：

HAEMATOLOGICA | 2019年 / 104卷 / 08期

关键词：

COAGULATION FACTOR-VIII; VONWILLEBRAND-FACTOR; FACTOR GENE; POLYMORPHISMS; MUTATIONS; IMMUNOGENICITY; ANTIBODIES; FVIII;

D O I：

10.3324/haematol.2018.212001

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：E369 / E372

页数：4

共 50 条

[41] von Willebrand factor: factor VIII protector and friend
Ragni, Margaret V.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2012, 10 (11) : 2324 - 2327
[42] Factor VIII, von Willebrand factor in colorectal cancer
Tuhta, A.
Yucel, I
Gonullu, G.
ANNALS OF ONCOLOGY, 2006, 17 : 81 - 81
[43] Kinetics of factor VIII von Willebrand factor association
Vlot, AJ
Koppelman, SJ
Meijers, JCM
Damas, C
vandenBerg, HM
Bouma, BN
Sixma, JJ
Willems, GM
BLOOD, 1996, 87 (05) : 1809 - 1816
[44] Clearance mechanisms of von Willebrand factor and factor VIII
Lenting, P. J.
van Schooten, C. J. M.
Denis, C. V.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2007, 5 (07) : 1353 - 1360
[45] Von willebrand factor factor VIII binding is not affected by the Arg89Gln polymorphism in von Willebrand factor
Nesbitt, IM
Goodeve, AC
Preston, FE
Peake, IR
THROMBOSIS AND HAEMOSTASIS, 1996, 76 (05) : 820 - 821
[46] Recombinant Factor VIII Combined With Recombinant Von Willebrand Factor In Patients With Severe Hemophilia A: A Prospective Clinical Study Of Safety and Pharmacokinetics
Lissitchkov, Toshko
Windyga, Jerzy
Konkle, Barbara A.
Draxler, Wolfgang
Chapman, Miranda
Wong, Wing-Yen
Sorensen, Benny
Ewenstein, Bruce M.
BLOOD, 2013, 122 (21)
[47] FACTOR-VIII AND VON-WILLEBRAND-FACTOR IN CARDIOLOGY PATIENTS
TILLI, F
CHANG, P
LUNDERGAN, C
ARONSON, D
THROMBOSIS AND HAEMOSTASIS, 1993, 69 (06) : 815 - 815
[48] A QUANTITATIVE ASSAY FOR FACTOR-VIII BINDING-CAPACITY OF VON-WILLEBRAND-FACTOR IN PLASMA
NISHINO, S
NISHINO, M
NISHIMURA, T
MIURA, S
SUGIMOTO, M
YOSHIOKA, A
THROMBOSIS AND HAEMOSTASIS, 1995, 73 (06) : 1173 - 1173
[49] RATE OF SYNTHESIS OF FACTOR-VIII AND DECAY OF FACTOR-VIII AND VON-WILLEBRAND-FACTOR (VWF) IN SEVERE VON-WILLEBRAND DISEASE (VWD)
MENACHE, D
ARONSON, DL
DARR, F
MONTGOMERY, RR
BLOOD, 1994, 84 (10) : A238 - A238
[50] Solution structure of the major factor VIII binding region on von Willebrand factor
Shiltagh, Nuha
Kirkpatrick, John
Cabrita, Lisa D.
McKinnon, Tom A. J.
Thalassinos, Konstantinos
Tuddenham, Edward G. D.
Hansen, D. Flemming
BLOOD, 2014, 123 (26) : 4143 - 4151

← 1 2 3 4 5 →